News

Pregnant women can use topical corticosteroids for short periods of time and in normal doses without posing a risk to the fetus, recent research suggests.

Sulforaphane, a naturally occurring compound in broccoli, may offer potential as a sunscreen additive, recent research indicates.

A standardized, online dermatology curriculum significantly improved dermatology knowledge among fourth year medical students enrolled in an introductory dermatology clerkship, according to a recent study.

The use of probiotics early in life may reduce atopic sensitization in children, a recent meta-analysis suggests.

Lateral canthal rhytids treated with three injections of abobotulinumtoxinA (Dysport, Medicis) showed no statistically significant difference from those treated with one injection, according to a study in the August issue of the Journal of Drugs in Dermatology.

Men with skin of color often have unique skincare needs. Thiis month’s special report features insight and clinical pearls from three industry experts on some of the best practices for caring for this group of patients.

The American Academy of Dermatology (AAD) Council on Science and Research’s Research Agenda work group has identified three keys areas - pruritus, cutaneous oncology and performance measurement and outcomes - to target in the future for continuing research in the dermatology specialty.

Are you wondering how your dermatology practice can draw in more patients? Social media is the ideal platform to share your brand’s story, connect directly with target audiences and influence their opinion about your practice.

Dr. Derm has become very successful in his 20 years of practice. He now runs 16 offices with 82 employees - most of them full-time. Among his many coveted employees is his 37-year-old nursing clinical coordinator. She has worked with him for more than 10 years and oversees all of the many nurses and medical assistants in the office. Her role is of enormous importance to Dr. Derm and for this she is paid well.

The human interleukin-12 and interleukin-23 (IL-12/IL-23) inhibitor ustekinumab (Stelara, Janssen) is effective and is well tolerated in patients who have active psoriatic arthritis.

Popular media coverage of purported links between isotretinoin and inflammatory bowel disease (IBD) are largely overblown, as are patients’ concerns regarding the risks of oral contraceptive pills (OCPs) for acne, according to an expert.

Successful cosmetic treatment of men with skin of color requires dermatologists to recognize their unique differences in anatomy and skin aging.

An accurate assessment of the potential cause of chronic pruritus, coupled by a careful selection of current standard treatments as well as new and emerging therapies, can be instrumental in helping to quell the symptoms of this sometimes severely debilitating condition.

Melasma is one of the most challenging aesthetic conditions we face in our dermatology practices. Driven by both internal (hormonal) and external (sun exposure) factors, melasma can be improved with sunscreen, topical bleaching agents, chemical peels, and laser and light sources, but long-term remission has proven elusive.

The field of alternative medicine is increasing in popularity among dermatologists in the United States, particularly among their patients. Though conventional treatment approaches can be effective in quelling the symptoms associated with atopic dermatitis and other cutaneous diseases and conditions, “natural” remedies can also be of significant value in carefully selected patients.

Results of a retrospective chart review revealed patients with melanoma who present with bulky axillary disease develop distant metastases very quickly, prompting the plan for a prospective study to examine the preoperative impact of shrinking tumors through the use of systemic therapy.

Dermatological side effects can occur with treatments for non-dermatological conditions, and consultation with a dermatologist may be a wise step in such cases.

Take a look at these new products available for dermatologists.

Treating existing scars can help dermatologists and other core aesthetic specialists build lasting relationships with patients, says an expert who spoke at Cosmetic Boot Camp.

Scientists have found that blocking the molecule TRPV4 can help to prevent the pain caused by sunburns.

Informed consent is a critical element of a strong physician-patient relationship. It is both a legal requirement and an ethical obligation that supports the physician in the face of litigation and protects the patient's autonomy in the decision-making process. An expert panel discusses what specific items are on their consent forms and how often they have patients re-consent when returning for aesthetic fillers or neuromodulators.

Up to 30 percent of patients with psoriasis do not seek medical care for their skin condition, patient surveys show.

Nurse practitioners (NPs) and physician assistants (PAs) are increasingly going to subspecialties to work, rather than in primary care, which may suggest that these healthcare providers won’t be a solution to the impending shortage of primary care physicians.

Figure 1, a free social medical photo-sharing app available for iOS in the iTunes store, has been gaining attention since it debuted early this summer.

Children with attention-deficit hyperactivity disorder (ADHD) may be more likely to have skin infections, impetigo and atopic diseases, a recent study shows.

Dermatologists should consider nuances of men's skin when developing treatment plans. For example, men's skin is thicker and may require additional laser passes in some areas.

Patients with psoriasis have increasingly higher chances of having at least one other major comorbidity when compared to patients who do not have psoriasis, study results indicate.

Photographs of skin cancers caused patients to be more likely to conduct skin self-examinations, according to results of a recent study.

A recent study confirms the presence of certain antibodies in patients with morphea, but only in linear morphea is the presence associated with clinical indicators of severity.

A topical application of tofacitinib may offer a future therapeutic option for patients with plaque psoriasis, according to a recent study.